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Mineralocorticoid and glucocorticoid receptors in human kidney.
Currently, studies on renal mineralocorticoid and glucocorticoid
receptors have been confined to experimental animals. In experi-
ments made upon human kidneys removed at operation, tritiated
aldosterone has been shown to bind specifically to a single class of
cytoplasmic sites which show steroid specificity requisite for phys-
iological mineralocorticoid receptors. Tritiated dexamethasone,
similarly, binds specifically to a single class of cytoplasmic sites
with affinity characteristics appropriate for glucocorticoid recep-
tors. The similarity between the human renal receptor profile for
adrenocorticoids and that found in experimental animals may
validate cautious extrapolation from animal models of adrenocor-
ticoid effector mechanisms to man.
Récepteurs aux mineralocorticoides et aux glucocorticoides au
niveau du rein humain. Habituellement, les &udes des récepteurs
renaux aux glucocorticoides et aux mineralocorticoides furent ré-
alisées seulement chez l'animal d'expérience. Dans des experiences
factes sur des reins humains prCleves lors d'operation, l'aldo-
sterone tritiée se fixe specifiquement au niveu d'une seule type
de site cytoplasmique qui présente exactement les caractéristiques
d'un recepteur physiologique aux mineralocorticoides. De méme Ia
dexamethasone tritiée se fixe specifiquement a one seule classe de
site cytoplasmique qui montre une aflinite caractCristique et appro-
priée aux récepteurs aux glucocorticoides. Cet aspect similaire des
récepteurs renaux humains et ceux des animaux d'expérience per-
met une extrapolation circonspecte des mécanismes effecteurs sur-
renaliens du modèle animal a l'homme.
Current concepts of the mechanism of action of
steroid hormones include an initial obligatory step of
binding to specific cytoplasmic receptors in target
tissue cells [I]. In kidney slices from adrenalecto-
mized rats, aldosterone has been shown to bind to
two classes of site with relatively high affinity [2, 3].
The first of these classes, designated type 1 sites, has a
very low affinity for glucocorticoids, and an affinity
for aldosterone appropriate for a physiological role
as mineralocorticoid receptors [3]. The second class
of sites to which aldosterone binds, in kidney slices
from adrenalectomized rats, has affinity character-
istics appropriate for glucocorticoid receptors [3, 4].
Mineralocorticoid receptors have similarly been
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described in the kidney of the adrenalectomized dog
[5] and sheep [6]. In the present study it was shown
that the binding of tritiated aldosterone in human
kidney slices is to sites with criteria requisite for
physiological mineralocorticoid receptors. In addi-
tion, the binding of tritiated dexamethasone, a potent
synthetic glucocorticoid, was studied. As in the rat
and dog kidney, the binding of dexamethasone is to
sites with affinity characteristics of glucocorticoid re-
ceptors.
Methods
Tritiated aldosterone (3HA, ' 50 Ci/mmole) and
tritiated dexamethasone (3HDM, 27 Ci/m mole) were
obtained from Amersham-Searle (U.K.). Unlabelled
dexamethasone (DM) was the generous gift of
Merck, Sharp and Dohme, Australia; unlabelled al-
dosterone (A), deoxycorticosterone (DOC), cortisol
(F), estradiol (E2), progesterone (P) and dihydrotestos-
terone (DHT) were all from Calbiochem (U.S.A.),
and of chromatography grade. Other reagents used
were analytical grade.
Human kidneys were obtained at nephrectomy for
a variety of conditions. A total of twelve kidneys was
studied; in four of these twelve specimens, adrenocor-
ticoid receptors could be defined with precision.
These four comprised the uninvolved pole of two
kidneys removed for neoplasm, one for tuberculosis
and an unsuccessful attempt at repair of renal artery
stenosis. Of the eight kidneys in which—despite ade-
quate amounts of tissue—insufficient isotope binding
was obtained to determine its affinity and specificity,
seven were removed for hydronephrosis and one for
neoplasm. Kidneys were used fresh, within 30 mm of
surgical excision.
Kidney slices were made, thickness SOOt, using a
commercial meat slicer, and rinsed at 37°C for 4 X 15
mm in incubating solution (Nat, 133; K, 6; Cl,
134; H2P04, 6; Ca, I; Mg, 0.5; Tris-HCI, 5;
glucose, 5; all in mM; pH, 7.4) in an attempt to
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remove endogenous steroid, both free and receptor-
bound. In rat kidney, disappearance of the cyto-
plasmic-bound aldosterone has been shown to parallel
plasma disappearance [7]. In a series of preliminary
experiments (unpublished results) on adrenalectomized
rat kidney slices prelabelled with 3HA, and then
rinsed as described above, specific rebinding upon re-
exposure to 3HA was shown to be 60% of zero
time (prerinse) levels.
After rinsing, kidney slices (0.3 to 1 g) were in-
cubated with constant agitation for 40 mm at 25°C
with 10 ml of incubating solution containing 3HA
plus tenfold unlabelled DM either alone or in the
presence of competing unlabelled steroid. Binding of
3HA to cytoplasmic fractions in the rat kidney at
25°C has been shown to reach plateau levels by 40
mm [8]. In studies upon the renal binding of 3HA in
the rat and sheep, the inclusion of tenfold unlabelled
dexamethasone has been shown to confine 3HA bind-
ing to type I, mineralocorticoid receptors [3, 6].
At the end of the period of incubation, an aliquot
of incubating solution was taken to determine levels
of 3HA directly; the slices were rinsed with ice-cold
incubating solution and homogenized in 1.5 ml of
0.25M sucrose—3mM CaCl2 by a five-second burst of a
homogenizer (Polytron P—b). This, and all sub-
sequent steps, were carried out at 0 4°C. Homoge-
nates were centrifuged for 30 mm at 30,000 X g in a
refrigerated centrifuge (Sorvall RC 2B), and the high
speed supernatant (HSS) used to determine cy-
toplasmic binding of 3HA. Protein-bound 3HA was
separated from residual free steroid by Sephadex G-
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Fig. 2. Scatchard plots of specific binding of tritiated aldosterone
(WA) inhuman kidney slices. Different symbols represent individual
kidneys.
50 (fine) gel filtration, a technique which has been
previously widely used in studies on cytoplasmic 3HA
receptors [3—8]. Aliquots of column fractions con-
taining protein-bound 3HA were divided for determi-
nation of radioactivity and protein concentration.
One-milliliter aliquots were added to 10 ml of counting
solution (I liter of toluene, 500 ml of Teric X-l0, 0.15
g of POPOP, 8.26 g of PPO), and counted for ten
minutes or l0 counts in a liquid scintillation spec-
trometer (Packard 3375), counting efficiency 45%,
Protein concentrations were determined by the method
of Warburg and Christian [9].
Binding studies using 3HDM were made on pre-
formed renal HSS. Rinsed slices were homogenized
with the Polytron in 0.25M sucrose—3 mM CaCI2, and
the homogenate was centrifuged for 30 mm at 30,000
X g. Aliquots of the resultant HSS (500tI) were
added to 5OOtl aliquots of homogenizing medium
containing 3HDM, alone or with competing unla-
belled steroids, and incubated for 90 mm at 4°C with
constant agitation. At the end of this period, the
entire incubate was subjected to Sephadex chroma-
tography; determination of protein-bound radio-
activity and protein concentration was as in the stud-
ies on 3HA binding.
Results
The specificity of the binding of 8HA in human
kidney slices is shown in Fig. 1. Plotted are the results
of duplicate determinations in two kidneys, where the
amount of tissue allowed detailed study. The hier-
archy of steroid affinity for aldosterone binding
sites—measured by the ability of unlabelled steroid to
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Fig. 1. Competition by unlabelled steroids for tritiated aldosterone
('HA) binding sites in human kidney slices. Binding in the presence
of tracer alone('HA + 10 DM)is expressed as 100%, and binding
in the presence of competing steroids as a percentage thereof.





costerone >> cortisol > progesterone > estradiol
dihydrotestosterone. This hierarchy is identical to
that established in the sheep [61; in the other two
kidneys, in which a limited number of single-point
determinations were made in the presence of 1000-
fold unlabelled competitor (not shown), the order
was similarly aldosterone > cortisol > progesterone
> estradiol  dihydrotestosterone. In both studies
the "nonspecific" binding—i.e., that not displaceable
by 1000-fold excess unlabelled aldosterone—was
50% of the total. The relatively high concentration of
3HA used is a partial explanation: nonspecific bind-
ing represented 20% of the total at 3HA 6 X 10-',
for example. Probably a more important contribu-
tion to the apparently high nonspecific binding is that
only a fraction of receptors survive after the operative
and rinsing procedures.
The affinity of the binding of 3HA in human kidney
slices is shown in Fig. 2. Kidney slices were incubated
with a range of concentrations of 3HA + 10 DM
(3HA 5 x l0, 2.5 >< I0, 1.25 >< 10-s, 6 x 10'°M)
and the specific binding was plotted by the method of
Scatchard. Solid symbols represent the mean of du-
plicates in each of two kidneys; open symbols repre-
sent single-point determination in each of two kid-
neys. In all four kidneys, the affinity of binding,
indicated by the slope of the line of best fit for each
set of points, is similar, and represents a Kd 25°C 2
X l0- M. Between kidneys a large variation in appar-
ent receptor concentration (indicated by the extrapo-
lated intercept upon the abscissa) can be seen. This
variability may reflect a true difference between kid-
100% neys, but the probability is that it represents different
degrees of receptor loss.
The specificity of 3HDM binding is shown in Fig.
3. Plotted are the results of duplicate determinations
in two kidneys. The hierarchy of affinity for 3HDM
binding sites is in the order dexamethasone> cortisol
> progesterone > aldosterone >> estradiol >
dihydrotestosterone. The affinity with which renal
glucocorticoid receptors bind 3HDM is shown in Fig.
4. Kidney HSS was incubated with 3HDM over a
range of concentrations(l07, 5 X 10-8, 2.5 X I0-8M,
etc.) In two experiments six points were determined in
duplicate (solid symbols); in two other experiments
four and five concentrations were studied in single-
point experiments (open symbols). The specific bind-
ing of 3HDM is shown as Scatchard plots. In all four
kidneys, the affinity of 3HDM binding is similar, and
represents a Kd 4°C '- 4 X lO8rsi. Between kidneys a
lesser variability in concentration of 3HDM binding
sites was seen, compared with mineralocorticoid re-
ceptors. This observation lends weight to the possi-
bility that the variability of 3HA binding reflects the
notorious lability of mineralocorticoid receptors [10,
II].
Discussion
The results documented herein can be summarized
as follows: 1) In human kidney slices, 3HA binds in
the presence of ten-fold DM to a single class of
binding sites. These sites have steroid specificity re-
quisite for physiological mineralocorticoid receptors,
and an approximate affinity for aldosterone repre-
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Fig. 3. Competition by unlabelled steroids for tritiated dexametha-
sane (3HDM) binding sites in human kidney cytoplasmic extracts.
Bindrng in the presence of %IDM alone is expressed as 100%, and








Specific binding of 3HDM, M
Fig. 4. Scatchard plots of specific binding of tritiated dexamethasone
(3HDM) in human kidney cytoplasmic extracts. Different symbols
represent different kidneys.
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sented by a Kd 25°C 2 X 1O-9M. 2) In human
kidney cytoplasmic extracts, 3HDM binds to a single
class of sites with steroid specificity appropriate for
glucocorticoid receptors, and with an approximate
affinity represented by a Kd 4°C 4 >< 10rvi.
There have been a number of studies of steroid
binding in human tissues [12—17], including several
on glucocorticoid binding [15—17]. The binding of
3HDM in kidney cytoplasmic extracts is to sites with
equivalent affinity to those found in other human
tissues; the human glucocorticoid receptor, however,
appears to have a lower affinity for dexamethasone
than do glucocorticoid receptors in the rat (K0 4°C
4 >< l0 vs. '- 1O8).
While the 3HA binding sites in the dog have ster-
oid specificity requisite for mineralocorticoid recep-
tors, no values are available for their K0 for aldoste-
rone. Human mineralocorticoid receptors, however,
have an affinity for aldosterone identical to that
found in the rat [8]. Mineralocorticoid receptors in
sheep kidney, similarly, have an affinity identical to
that found in the rat [6]. The possibility exists, ac-
cordingly, that among the rat, sheep and man there
will be found a high degree of homology in the struc-
ture of mineralocorticoid receptors, and suggests that
studies on mineralocorticoid mechanisms in animal
models may be validly, if cautiously, extrapolated to
man.
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